Published in Nano Today on February 01, 2016
Organic chemistry meets polymers, nanoscience, therapeutics and diagnostics. Beilstein J Org Chem (2016) 0.76
Spatial and Structural Metrics for Living Cells Inspired by Statistical Mechanics. Sci Rep (2016) 0.75
Principles of protein-protein interactions. Proc Natl Acad Sci U S A (1996) 14.51
The atomic structure of protein-protein recognition sites. J Mol Biol (1999) 12.63
Renal clearance of quantum dots. Nat Biotechnol (2007) 12.54
Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett (2006) 10.12
Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature (2007) 9.12
Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol (2008) 8.23
Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov (2004) 7.84
Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett (2007) 5.48
The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng (2012) 4.31
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev (2009) 4.06
Design considerations for tumour-targeted nanoparticles. Nat Nanotechnol (2009) 4.06
Stimuli-responsive nanocarriers for drug delivery. Nat Mater (2013) 3.52
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol (2013) 3.39
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev (2009) 3.08
Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations. Environ Sci Technol (2005) 3.05
The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles. Nat Nanotechnol (2011) 2.98
Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles. Nano Lett (2007) 2.68
A quantum dot conjugated sugar ball and its cellular uptake. On the size effects of endocytosis in the subviral region. J Am Chem Soc (2004) 2.49
Minimal "Self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles. Science (2013) 2.42
Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. Angew Chem Int Ed Engl (2003) 2.37
Protein-nanoparticle interactions: opportunities and challenges. Chem Rev (2011) 2.34
Understanding the role of surface charges in cellular adsorption versus internalization by selectively removing gold nanoparticles on the cell surface with a I2/KI etchant. Nano Lett (2009) 2.15
Spherical nucleic acids. J Am Chem Soc (2012) 2.09
Structure of alpha-chymotrypsin refined at 1.68 A resolution. J Mol Biol (1985) 2.08
The origins and evolution of "controlled" drug delivery systems. J Control Release (2008) 2.05
The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials (2009) 1.82
Effect of nanoparticle surface charge at the plasma membrane and beyond. Nano Lett (2010) 1.77
Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. J Control Release (2007) 1.73
Functionalizing nanoparticles with biological molecules: developing chemistries that facilitate nanotechnology. Chem Rev (2013) 1.69
Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. Bioconjug Chem (2002) 1.68
Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells. J Am Chem Soc (2009) 1.67
Transferrin-mediated gold nanoparticle cellular uptake. Bioconjug Chem (2005) 1.64
Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles. PLoS One (2011) 1.53
Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles. ACS Nano (2010) 1.46
Nano meets biology: structure and function at the nanoparticle interface. Langmuir (2011) 1.43
Cellular uptake and toxicity of gold nanoparticles in prostate cancer cells: a comparative study of rods and spheres. J Appl Toxicol (2010) 1.38
pH-Induced aggregation of gold nanoparticles for photothermal cancer therapy. J Am Chem Soc (2009) 1.38
Surface functionalization of nanoparticles for nanomedicine. Chem Soc Rev (2012) 1.38
Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. J Pharmacol Exp Ther (2000) 1.32
A tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug delivery. Angew Chem Int Ed Engl (2010) 1.26
Synthesis, characterization, and intracellular uptake of carboxyl-terminated poly(amidoamine) dendrimer-stabilized iron oxide nanoparticles. Phys Chem Chem Phys (2007) 1.20
Inhibition of chymotrypsin through surface binding using nanoparticle-based receptors. Proc Natl Acad Sci U S A (2002) 1.19
A new concept for the mechanism of action of chymotrypsin: the role of the low-barrier hydrogen bond. Biochemistry (1997) 1.13
Beauty is skin deep: a surface monolayer perspective on nanoparticle interactions with cells and bio-macromolecules. Small (2011) 1.08
Fabrication of corona-free nanoparticles with tunable hydrophobicity. ACS Nano (2014) 1.07
A protein nanocarrier from charge-conversion polymer in response to endosomal pH. J Am Chem Soc (2007) 1.06
Enhanced retention and cellular uptake of nanoparticles in tumors by controlling their aggregation behavior. ACS Nano (2013) 1.03
BSA adsorption on differently charged polystyrene nanoparticles using isothermal titration calorimetry and the influence on cellular uptake. Macromol Biosci (2011) 1.03
Contrasting effects of exterior and interior hydrophobic moieties in the complexation of amino acid functionalized gold clusters with alpha-chymotrypsin. Org Lett (2005) 1.01
Multidentate zwitterionic ligands provide compact and highly biocompatible quantum dots. J Am Chem Soc (2013) 1.01
Charged gold nanoparticles with essentially zero serum protein adsorption in undiluted fetal bovine serum. J Am Chem Soc (2013) 0.98
Disruption of protein-protein interactions using nanoparticles: inhibition of cytochrome c peroxidase. Chem Commun (Camb) (2006) 0.96
The interplay of monolayer structure and serum protein interactions on the cellular uptake of gold nanoparticles. Small (2012) 0.89
Acylsulfonamide-Functionalized Zwitterionic Gold Nanoparticles for Enhanced Cellular Uptake at Tumor pH. Angew Chem Int Ed Engl (2015) 0.88
Synthetic "chaperones": nanoparticle-mediated refolding of thermally denatured proteins. Chem Commun (Camb) (2008) 0.88
Controlled pH stability and adjustable cellular uptake of mixed-charge nanoparticles. J Am Chem Soc (2013) 0.87
Isomeric control of protein recognition with amino acid- and dipeptide-functionalized gold nanoparticles. Chemistry (2008) 0.86
Carbonic anhydrase inhibitor coated gold nanoparticles selectively inhibit the tumor-associated isoform IX over the cytosolic isozymes I and II. J Am Chem Soc (2008) 0.85
Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae. Proc Natl Acad Sci U S A (2014) 0.84
The role of ligand coordination on the cytotoxicity of cationic quantum dots in HeLa cells. Nanoscale (2013) 0.83
Hydrophilic gold nanoparticles adaptable for hydrophobic solvents. Langmuir (2012) 0.82
Peptide-capped gold nanoparticles: towards artificial proteins. Chembiochem (2006) 0.80
Engineering the interface between glucose oxidase and nanoparticles. Langmuir (2012) 0.80
Carbonic anhydrase activators: gold nanoparticles coated with derivatized histamine, histidine, and carnosine show enhanced activatory effects on several mammalian isoforms. J Med Chem (2011) 0.80
Striking improvement in peroxidase activity of cytochrome c by modulating hydrophobicity of surface-functionalized gold nanoparticles within cationic reverse micelles. Chemistry (2012) 0.78
Ready separation of proteins from nucleoprotein complexes by reversible modification of lysine residues. Biochem J (1980) 0.78
Enhanced cellular uptake of amphiphilic gold nanoparticles with ester functionality. Chem Commun (Camb) (2014) 0.78
Surface-chemistry effect on cellular response of luminescent plasmonic silver nanoparticles. Bioconjug Chem (2014) 0.76
Reversible modification of lysine in soybean proteins, using citraconic anhydride: characterization of physical and chemical changes in soy protein isolate, the 7S globulin, and lipoxygenase. J Agric Food Chem (1981) 0.76
Externally controlled drug release using a gold nanorod contained composite membrane. Nanoscale (2016) 0.83
Facile synthesis of cationic gold nanoparticles with controlled size and surface plasmon resonance. RSC Adv (2016) 0.75
Correction: Externally controlled drug release using a gold nanorod contained composite membrane. Nanoscale (2016) 0.75